Maxcyte, Inc.: Form 8-K, filed Mar 22, 2022
Filed with the SEC on Mar 22, 2022 and accepted by EDGAR at Mar 22, 2022, 16:15 ET.
Items reported
- Item 2.02 Results of operations
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001558370-22-004073. Last ingested by Listed: Nov 2, 2026, 10:20 ET. Listed shows no prices and gives no investment advice.